ObjectiveToexplorethedynamicchangesofoxidativestressandcytokinesinMongoliangerbilswith nonalcoholic fatty liver disease ( NAFLD) and their significance.Methods Forty-eight healthy male gerbils were randomly divided into normal group and model group , 24 in each group .Gerbils of the model group were fed with high fat diet while those of the normal group with normal diet .Eight gerbils in each group were killed at the end of 4 w, 8 w and 16 w, respectively .MDA content and SOD , GSH-PX and T-AOC activity in the liver tissue were detected by chemical method, and serum TNF-α, INF-γand IL-10 levels were determined using liquid suspension chip .Results With the development of NAFLD , MDA content in liver increased gradually , and the MDA contents were all significantly higher than those of the normal group ( P<0.01 ); T-AOC level slightly increased , and then decreased , the levels at 4 w and 16 w were markedly decreased compared with those of the normal group (P<0.05);SOD level was significantly increased and then markedly reduced, the level of the model group at 4 w was significantly increased (P<0.05), while that at 8 w and 16 w were significantly decreased (P<0.05, P<0.01).The level of GSH-PX was decreased gradually , the levels at 8 w and 16 w were significantly lower than those of the normal group (P<0.05).With the progression of NAFLD,serum TNF-αand IFN-γwere increased gradually , while the level of IL-10 decreased gradually , and the levels at 8 w and 16 w were significantly lower than those of the normal group ( P <0.05, P <0.01).Conclusions The oxidative stress-related indicators and inflammatory cytokines in the gerbil NAFLD models induced by high fat diet are significantly changed as simple fatty liver develops into steatohepatitis , liver fibrosis and cirrhosis , and participate in the development and progression of NAFLD .

Objective:To explore the clinical effects of tuina therapy of Yinyang Ruyin combined with aromatherapy on insomnia and quality of life in patients receiving perichemotherapy for breast cancer.Methods:Totally 199 inpatients with insomnia who received perichemotherapy for breast cancer from June 2018 to December 2019 and met inclusion and exclusion criteria were selected and divided into the control group ( n=48) , the tuina therapy of Yinyang Ruyin group ( n=50) , the aromatherapy group ( n=52) , and the combined treatment group ( n=49) according to the computer-generated random sequence. Patients in the control group received routine care; patients in the tuina therapy of Yinyang Ruyin group received tuina therapy of Yinyang Ruyin on this basis; patients in the aromatherapy group received aromatherapy on this basis; patients in the combined treatment group received both tuina therapy of Yinyang Ruyin and aromatherapy. After 6 cycles of chemotherapy, Pittsburgh Sleep Quality Index (PSQI) , Hamilton Depression Scale (HAMD) , and Functional Assessment of Cancer Therapy: General (FACT-G) were used to evaluate the intervention effects of the four groups. Results:The amelioration rates of insomnia in the 3 and 6 chemotherapy cycles after the intervention of the tuina therapy of Yinyang Ruyin group, the aromatherapy group, and the combined treatment group were higher than that of the control group ( P<0.05) ; the amelioration rates of insomnia in the 3 and 6 chemotherapy cycles after the intervention of the combined treatment group was higher than those of the tuina therapy of control group, Yinyang Ruyin group and the aromatherapy group ( P<0.05) . The repeated measures analysis of variance showed that the main effects of intervention in the PSQI, HAMD, and FACT-G scores of the four groups were statistically different ( P<0.05) ; the time of main effects of PSQI, HAMD, and FACT-G scores was significantly different ( P<0.05) ; there was an interaction between the intervention factors of PSQI, HAMD, and FACT-G scores and the time factor ( P<0.05) . Conclusions:Tuina therapy of Yinyang Ruyin combined with aromatherapy can ameliorate the symptoms of insomnia and depression, thereby improving the quality of life of patients.